Drug repositioning by integrating target information through a heterogeneous network model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24974205.
- Also identified by DOI 10.1093/bioinformatics/btu403 and PMC identifier 4184255.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emergence of network medicine not only offers more opportunities for better and more complete understanding of the molecular complexities of diseases, but also serves as a promising tool for identifying new drug targets and establishing new relationships among diseases that enable drug repositioning. Computational approaches for drug repositioning by integrating information from multiple sources and multiple levels have the potential to provide great insights to the complex relationships among drugs, targets, disease genes and diseases at a system level. In this article, we have proposed a computational framework based on a heterogeneous network model and applied the approach on drug repositioning by using existing omics data about diseases, drugs and drug targets. The novelty of the framework lies in the fact that the strength between a disease-drug pair is calculated through an iterative algorithm on the heterogeneous graph that also incorporates drug-target information. Comprehensive experimental results show that the proposed approach significantly outperforms several recent approaches. Case studies further illustrate its practical usefulness. http://cbc.case.edu jingli@cwru.edu Supplementary data are available at Bioinformatics online.
Medical subject headings
- Computational Biology
- Drug Repositioning
- Models, Theoretical
- Molecular Targeted Therapy